Boothbay Fund Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $324K | Sell |
3,735
-5,735
| -61% | -$549K | ﹤0.01% | 1576 |
|
|
2025
Q4 | $910K | Buy |
9,470
+6,776
| +252% | +$658K | 0.01% | 833 |
|
|
2025
Q3 | $257K | Buy |
2,694
+335
| +14% | +$30.8K | ﹤0.01% | 1529 |
|
|
2025
Q2 | $206K | Sell |
2,359
-9,647
| -80% | -$818K | ﹤0.01% | 1241 |
|
|
2025
Q1 | $1.08M | Sell |
12,006
-65,565
| -85% | -$5.87M | 0.03% | 602 |
|
|
2024
Q4 | $6.2M | Buy |
77,571
+74,516
| +2,439% | +$6.45M | 0.15% | 190 |
|
|
2024
Q3 | $275K | Sell |
3,055
-17,312
| -85% | -$1.46M | 0.01% | 1289 |
|
|
2024
Q2 | $1.6M | Sell |
20,367
-182,535
| -90% | -$15M | 0.04% | 574 |
|
|
2024
Q1 | $17.7M | Buy |
202,902
+111,159
| +121% | +$9.49M | 0.34% | 37 |
|
|
2023
Q4 | $7.56M | Sell |
91,743
-119,321
| -57% | -$9.09M | 0.19% | 104 |
|
|
2023
Q3 | $16.5M | Buy |
211,064
+132,759
| +170% | +$11.1M | 0.39% | 35 |
|
|
2023
Q2 | $6.9M | Buy |
+78,305
| New | +$6.74M | 0.15% | 143 |
|
|
2023
Q1 | – | Sell |
-37,233
| Closed | -$2.89M | – | 2368 |
|
|
2022
Q4 | $2.89M | Buy |
37,233
+14,820
| +66% | +$1.2M | 0.07% | 438 |
|
|
2022
Q3 | $1.81M | Sell |
22,413
-11,033
| -33% | -$992K | 0.05% | 617 |
|
|
2022
Q2 | $3M | Sell |
33,446
-18,071
| -35% | -$1.83M | 0.08% | 382 |
|
|
2022
Q1 | $5.72M | Sell |
51,517
-33,489
| -39% | -$3.54M | 0.13% | 176 |
|
|
2021
Q4 | $8.79M | Buy |
85,006
+60,908
| +253% | +$7.05M | 0.21% | 99 |
|
|
2021
Q3 | $3.02M | Sell |
24,098
-57,006
| -70% | -$7.38M | 0.08% | 297 |
|
|
2021
Q2 | $10.1M | Buy |
81,104
+15,103
| +23% | +$1.9M | 0.32% | 51 |
|
|
2021
Q1 | $7.8M | Buy |
66,001
+39,671
| +151% | +$4.65M | 0.29% | 56 |
|
|
2020
Q4 | $3.08M | Buy |
26,330
+422
| +2% | +$46.5K | 0.11% | 164 |
|
|
2020
Q3 | $2.69M | Buy |
25,908
+7,067
| +38% | +$710K | 0.16% | 151 |
|
|
2020
Q2 | $1.73M | Buy |
18,841
+6,700
| +55% | +$642K | 0.12% | 236 |
|
|
2020
Q1 | $1.09M | Sell |
12,141
-10,826
| -47% | -$1.15M | 0.09% | 281 |
|
|
2019
Q4 | $2.61M | Buy |
22,967
+7,973
| +53% | +$875K | 0.23% | 112 |
|
|
2019
Q3 | $1.63M | Buy |
+14,994
| New | +$1.56M | 0.15% | 188 |
|
|
2018
Q2 | – | Sell |
-4,477
| Closed | -$359K | – | 838 |
|
|
2018
Q1 | $359K | Buy |
+4,477
| New | +$369K | 0.04% | 409 |
|
|
2017
Q4 | – | Sell |
-3,101
| Closed | -$241K | – | 773 |
|
|
2017
Q3 | $241K | Buy |
+3,101
| New | +$257K | 0.04% | 448 |
|
|
2017
Q2 | – | Sell |
-6,320
| Closed | -$509K | – | 772 |
|
|
2017
Q1 | $509K | Sell |
6,320
-4,202
| -40% | -$328K | 0.09% | 256 |
|
|
2016
Q4 | $749 | Buy |
+10,522
| New | +$827K | 0.17% | 139 |
|
|
2016
Q3 | – | Sell |
-2,970
| Closed | -$258K | – | 767 |
|
|
2016
Q2 | $258K | Sell |
2,970
-687
| -19% | -$55.6K | 0.1% | 293 |
|
|
2016
Q1 | $274K | Buy |
+3,657
| New | +$275K | 0.2% | 160 |
|
Other funds holding MDT
VCM
VPM
Boothbay Fund Management's MDT Position: Q1 2026 in Review
Boothbay Fund Management reduced its Medtronic (MDT) stake by 61% in Q1 2026, selling an estimated $549K and leaving 3,735 shares worth $324K. The position accounts for ﹤0.01% of the portfolio, ranked #1576.
Boothbay Fund Management first reported a position in MDT in Q1 2016 and has held it in 32 quarters since. The position peaked at $17.7M in Q1 2024. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.
- Boothbay Fund Management held 3,735 shares of Medtronic worth $324K as of Q1 2026.
- Boothbay Fund Management sold 5,735 Medtronic shares in Q1 2026, an estimated $549K.
- Medtronic made up ﹤0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1576 holding.
- Boothbay Fund Management first reported a position in Medtronic in Q1 2016 and has held it in 32 quarters since.
- Boothbay Fund Management's Medtronic position peaked at $17.7M in Q1 2024.
- 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.
Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.